Evidence map›Paper›PMID 24247900›Full record

ArticleTransplantation2013

Knockdown of intraislet IKKβ by spherical nucleic acid conjugates prevents cytokine-induced injury and enhances graft survival.

Jonathan S Rink, Kaylin M McMahon, Xiaomin Zhang, Xiaojuan Chen, Chad A Mirkin, C Shad Thaxton, Dixon B Kaufman

Open access · greenAbstract readComparative Study
In one paragraph

Article in Transplantation, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Unprecedently high targeting specificity toward lung ICAM-1 using 3DNA nanocarriers.Journal of controlled release : official journal of the Controlled Release Society · 2019
    Article
  4. Article
  5. IL-1β reciprocally regulates chemokine and insulin secretion in pancreatic β-cells via NF-κB.American journal of physiology. Endocrinology and metabolism · 2015
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Jonathan S Rink1 Department of Urology, Northwestern University, Chicago, IL. 2 Institute for BioNanotechnology in Medicine, Northwestern University, Chicago, IL. 3 Comprehensive Transplant Center, Northwestern University, Chicago, IL. 4 Department of Surgery, Northwestern University, Chicago, IL. 5 Columbia Center for Translational Immunology, Columbia University, New York, NY. 6 International Institute for Nanotechnology, Northwestern University, Evanston, IL. 7 Department of Chemistry, Northwestern University, Evanston, IL. 8 Division of Transplantation, Department of Surgery, University of Wisconsin, Madison, WI. 9 Address correspondence to: Dixon B. Kaufman, M.D., Ph.D., Division of Transplantation, Department of Surgery, University of Wisconsin, H5/701 Clinical Sciences Center, 600 Highland Avenue, Madison, WI 53792-7375.
Kaylin M McMahon
Xiaomin Zhang
Xiaojuan Chen
Chad A Mirkin
C Shad Thaxton
Dixon B Kaufman
Northwestern University · USColumbia University · USUniversity of Wisconsin–Madison · US

Funding

Tumor Environment and Metastasis (TEAM) Research ProgramP30CA060553 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Daniela E Matei · 1993 to 2026
$153.9M
Theranostic Magnetic Nanostructures for the Molecular Imaging of CancerU54CA151880 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI MIRKIN, CHAD A. · 2010 to 2014
$11.5M
Howard Hughes Medical InstituteNCI NIH HHS NCI CA060553NCI NIH HHS P30 CA060553
6 · The paper itself

Abstract

backgroundThe efficiency of islet graft survival after intraportal implantation is compromised by host innate immune responses and the production of proinflammatory cytokines that cause acute cellular injury. This reaction activates intraislet nuclear factor-κB (NF-κB), causing production of gene products that have detrimental effects on β-cell survival and function. We hypothesized that small interfering RNA targeting of IKKβ, a crucial kinase in the NF-κB activation pathway, in islets before transplantation would ameliorate the detrimental effects of cytokines and improve islet survival after transplantation.

methodsTo test this hypothesis, we prepared small interfering RNA-based spherical nucleic acid nanoparticle conjugates targeting IKKβ IKKβ SNA-NCs). We treated isolated islets with IKKβ SNA-NCs and assessed the functional consequences of IKKβ knockdown in vitro and after intraportal transplantation in mice.

resultsTreatment of freshly isolated mouse islets with IKKβ SNA-NCs reduced constitutive IKKβ expression and protected against proinflammatory cytokine-induced NF-κB activation, resulting in improved cell viability and decreased expression of gene products associated with β-cell dysfunction. Intraportal transplantation of a marginal mass (50 islets) of syngeneic islets treated with nanoparticle conjugates targeting IKKβ resulted in reversion to normoglycemia in 50% of streptozotocin-induced diabetic recipients (n=12) compared with 0% of controls (n=12). Histologic analyses showed reduced CD11b(+) cellular infiltration and decreased islet apoptosis.

conclusionsThese results are consistent with the hypothesis that inhibition of intraislet NF-κB activation ameliorates the detrimental effects of host cytokines and demonstrates that preconditioning freshly isolated islets in culture with IKKβ SNA-NCs may be a promising therapy to enhance islet graft function and survival after transplantation.

Indexed as

Gene Expression RegulationIslets of Langerhans TransplantationAnimalsApoptosisCytokinesDiabetes Mellitus, ExperimentalGraft RejectionGraft SurvivalI-kappa B KinaseMiceMice, KnockoutPolymerase Chain ReactionRNACytokinesI-kappa B KinaseRNA

Identifiers

PMID24247900
PMCPMC3839058
OpenAlexW1986015192

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.